UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000026243
Receipt number R000030142
Scientific Title Comparison between two separate injections and single injection for double dose Gadolinium enhanced MRI of metastatic brain tumors.
Date of disclosure of the study information 2017/02/22
Last modified on 2017/02/21 12:20:17

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Comparison between two separate injections and single injection for double dose Gadolinium enhanced MRI of metastatic brain tumors.

Acronym

Two separate injections and single injection for double dose Gadolinium enhanced MRI of metastatic brain tumors.

Scientific Title

Comparison between two separate injections and single injection for double dose Gadolinium enhanced MRI of metastatic brain tumors.

Scientific Title:Acronym

Two separate injections and single injection for double dose Gadolinium enhanced MRI of metastatic brain tumors.

Region

Japan


Condition

Condition

metastatic brain tumor

Classification by specialty

Radiology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

The purpose of the current study is to evaluate number of injections and image acquisition by comparing a method using two separate injections to a method using a single injection for lesion enhancement, detection and delineation for a double-dose contrast material study for brain metastasis.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Number of visualized lesions

Key secondary outcomes

Visualization of the edge or internal structure of the lesions


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -but assessor(s) are blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Diagnosis

Type of intervention

Medicine

Interventions/Control_1

two separate injections group

Interventions/Control_2

single injection group.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

40 years-old <=

Age-upper limit

90 years-old >=

Gender

Male and Female

Key inclusion criteria

Cases in which metastatic brain tumor is suspected

Key exclusion criteria

Cases with serious side effect.
Cases with hypersensitivity with Gadoteridol.
Cases with serious renal dysfunction.

Target sample size

60


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Toshiaki Taoka

Organization

Nara Medical University Hospital

Division name

Department of Radiology

Zip code


Address

840 Shijo-cho Kashihara, Nara

TEL

0744-22-3051

Email

ttaoka@naramed-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Toshiaki Taoka

Organization

Nara Medical University Hospital

Division name

Department of Radiology

Zip code


Address

840 Shijo-cho Kashihara, Nara

TEL

0744-22-3051

Homepage URL


Email

ttaoka@naramed-u.ac.jp


Sponsor or person

Institute

Nara Medical University

Institute

Department

Personal name



Funding Source

Organization

Nara Medical University

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2017 Year 02 Month 22 Day


Related information

URL releasing protocol

https://www.jstage.jst.go.jp/article/mrms/13/4/13_2013-0068/_article

Publication of results

Published


Result

URL related to results and publications

https://www.jstage.jst.go.jp/article/mrms/13/4/13_2013-0068/_article

Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2010 Year 02 Month 04 Day

Date of IRB


Anticipated trial start date

2010 Year 03 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2017 Year 02 Month 21 Day

Last modified on

2017 Year 02 Month 21 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000030142


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name